Project Grant R15DA064537
Award Date 9/1/25
Completion Date 8/31/28
Dollars Obligated $555K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Bakersfield, CA 93311, USA
Similar Awards
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $4,725,000 to the University of California, Los Angeles (UCLA) to develop new dissemination strategies that improve the availability and user-friendliness of research on preventing HIV transmission and effectively treating substance use disorders (SUDs). The project aims to mitigate policy-level barriers and upstream barriers that hinder access...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $200,772 Project Grant to Pennsylvania State University under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will fund a study to develop and evaluate the implementation of harm reduction-focused smart vending machines (SVMs) that deliver naloxone, fentanyl test strips, and other public health items to underserved populations impacted by substance use disorders and...
- This Project Grant award of $1,573,958 from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on identifying individuals who are viremic and/or have substance use disorder (SUD) to engage them for early intervention. The project will implement routine SUD screening using the NIDA Quick Screen and a social network intervention to find individuals who are viremic, have SUD, or both, and link them to harm reduction and HIV...
- The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $687,416 Project Grant to the J. David Gladstone Institutes in San Francisco, California. The grant is for a research project titled "Targeted Small Molecule Recruitment to Suppress the HIV Transcriptionally Active Reservoir" and runs from May 15, 2025 to March 31, 2030. The key objectives of this research project are to develop therapeutically effective...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $775,550 to Yale University to conduct a cluster randomized controlled trial of the HOPE (Help OAT Prison Engagement) intervention. HOPE is a 6-week program tailored to the high-risk prison environment in Kyrgyzstan, with the goal of increasing uptake of opioid agonist therapy (OAT) and syringe service programs (SSP) to prevent HIV in...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $677,250 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Miami. The grant, awarded on June 15, 2025, supports the development and testing of the "Healthcare Empowerment and Advocacy for Recovery from Trafficking (HEART) Intervention" for implementation in syringe service programs. The project aims to engage women with experiences of...
- This Project Grant award of $2,332,500.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to transform systems of care in Washington state prisons to better address HIV, HIV risk, and substance use disorders. The key products and services to be delivered include: Building the foundation for a "prison learning health system" to improve the quality, efficiency, and reach of HIV treatment, HIV prevention, and...
- This Project Grant award of $1,607,146.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of a technology-based intervention to encourage drug checking, distribution of harm reduction supplies, and linkage to services for people who use drugs. The project, titled "Together Against Overdose: Community Developed Technology to Encourage Drug Checking, Distribution of Harm Reduction Supplies, and...
- This federal Project Grant award of $1,210,300 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development of novel polyvalent HIV vaccines to protect people who inject drugs (PWID) against intravenous HIV transmission. The project aims to create a vaccine that can elicit high levels of immune responses to rapidly clear multiple HIV strains that may be transmitted through needle use. The grant was awarded to Beth...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $426,036 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Tulane University. The award will fund a study to examine the feasibility and acceptability of a virtual reality-based mindfulness intervention, called "TRIPP," to support people with comorbid HIV and substance use disorders. This population faces significant public health challenges, as substance...